Close Menu

NEW YORK — NowDiagnostics said on Tuesday that it has received CE marking for its AdexusDx COVID-19 antibody test for SARS-CoV-2.

The test is designed to detect immunoglobulin G, M, and A antibodies against SARS-CoV-2 using a single drop of whole blood, plasma, or serum, according to the Springdale, Arkansas-based company. Results are provided within 15 minutes.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.